Linden Capital Partners and Northlane Capital Partners completed the merger of their portfolio companies Chesapeake IRB and Schulman IRB, respectively, to create Advarra, the premier provider of institutional review board (IRB), institutional biosafety committee (IBC),...
Advarra
Healthcare
Central Institutional Review Board (“IRB”) focused on providing legally mandated oversight functions for research conducted on human subjects as part of the clinical trial process. Advarra was formed in November 2017 through the merger of Chesapeake IRB and Schulman IRB. Northlane Capital Partners originally invested in Schulman IRB in December 2014.
Related Team Members
